Haemorheologic agents
Xanthine derivatives that make blood flow more easily through narrowed small vessels. Pentoxifylline is used for intermittent claudication.
What they are
Purine (xanthine) derivatives grouped by the WHO ATC system under peripheral vasodilators (C04AD). Pentoxifylline is the member in common use; it lengthens walking distance modestly in intermittent claudication and supports, but does not replace, exercise, smoking cessation and revascularisation. Cilostazol, the other drug for claudication, is on the antiplatelets page.
Mechanism of action
These drugs are related to caffeine and theophylline and inhibit phosphodiesterases. Red cells become more flexible, blood viscosity falls and white cells adhere and activate less, so blood passes more easily through narrowed small vessels in the limbs.
Target: Phosphodiesterases in blood cells (non-selective)
Drugs in this class
Others in the class
- Pentifylline
- Xantinol nicotinate
- Etofylline nicotinate
Test yourself
Think of the answer, then tap the question to see it.
What do haemorheologic agents change to improve flow in claudication?
The blood itself: red cells become more flexible and viscosity falls.
Which recent bleeding rules out pentoxifylline?
A recent cerebral or retinal haemorrhage.
Which bronchodilator's levels rise with pentoxifylline?
Theophylline.
Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.
Sources: Pentoxifylline: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2017); PENTOXIFYLLINE tablet, extended release (DailyMed (U.S. National Library of Medicine), 2026); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
